The pharma industry is paying close attention to how regulatory decisions and actions affect its day-to-day operations. From approvals to pricing to product listing, understanding the regulator’s scope of authority is vital.
Join members of Torys’ Life Sciences and Litigation practices as they discuss likely scenarios these companies could face and ways to handle them.
The following issues will be discussed.
- Constitutional and administrative law attacks: PMPRB regulations case study.
- What to do when the regulator comes knocking: procedural and substantive review.
- “But the guidance says…” How to deal with guidance documents.
- CADTH, PCPA and other non-legislative authorities—what are your options?
Lunch | 12:00 p.m.
Session | 12:30 - 1:30 p.m.
Ontario: This program is eligible for 1 Substantive hour.
To register for this event please email, [email protected].
